TABLE 2.
Antibiotic susceptibility of clinical isolates in MHB-ca and ASM(+)
| Antibiotic | MIC (mg/liter) |
|||||||
|---|---|---|---|---|---|---|---|---|
| 616 (PA921)a |
3807 (PA970)a |
154-1 (PA1024)b |
193-2 (PA1060)b |
|||||
| MHB-ca | ASM(+)c | MHB-ca | ASM(+) | MHB-ca | ASM(+) | MHB-ca | ASM(+) | |
| Ciprofloxacin | 0.5 | 0.5 | 0.032 | 0.064 | 0.5 | 0.5 | 2 | 2 |
| Ceftazidime | 2 | 0.5 | 1 | 1 | 2 | 0.5 | 2 | 1 |
| Meropenem | 0.125 | 0.064 | 0.125 | 0.064 | 0.5 | 1 | 2 | 4 |
| Tobramycin | 4 | 4 | 2 | 1 | 4 | 8 | 1 | 2 |
| Colistin | 2 | 2 | 2 | 4 | 2 | 4 | 1 | 8 |
a
Laboratoire de Bactériologie, Hôpital Jean Minjoz, Besançon, France.
b
University Hospital Münster, Münster, Germany.
c
MICs were determined by counting of the number of CFU after plating due to the turbidity of the medium.